Sabiha Iqbal, Mirza Zeeshan Sikandar, Syed Imran Ali Shah, Tashfeen Ikram, Iram Imran, Shaheena Naz


Background: Obesity is a worldwide medical menace with a huge health-economic burden. Glucose metabolism can be regulated by cellular magnesium in many ways; by mediating secretions of insulin and enabling receptor interaction of insulin. The objective of this study was to determine correlation between serum magnesium levels and insulin resistance in obese male subjects and compares with non-obese male.

Material and Methods: This cross sectional study was conducted at Central Park Medical College from December 2021 to May 2022 on 40 obese and 40 non-obese males. Homeostasis model assessment for insulin resistance (HOMA-IR) index was used for determining insulin resistance and magnesium levels were assessed by using atomic absorption spectrophotometry.

Results: A significantly low serum magnesium level was found in obese subjects as compared to controls (mean ±SD 1.356 ±0.215 vs. 1.79 ±0.267 mg/dl, p<0.0001). A significantly high HOMA-IR index was found in obese group than non-obese group (median (IQR); 3.12(2.65-3.46) vs. 1.61(1.46-1.83; p<0.0001).

Conclusion: The study showed significantly lower serum magnesium level and higher insulin resistance in obese men as compared to non-obese. The study has also shown that serum magnesium is negatively correlated with IR. Lower serum magnesium levels and HOMA-IR indices were observed in obese group as compared to non-obese group.


Obesity; Magnesium; Insulin Resistance HOMA-IR; Diabetes Mellitus.

Full Text:



American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care 2014;1(37):81-90.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 2004;27(5):1047-53.

Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ 2018; 8(8):e020961.

Forst T, Standl E, Hohberg C, Konrad T, Schulze J, Strotmann HJ, et al. IRIS II study: the IRIS II score-assessment of a new clinical algorithm for the classification of insulin resistance in patients with type 2 diabetes. Diabetic medicine 2004;21(10):1149-53.

Muoio DM, Newgard CB. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nature reviews Molecular cell biology 2008;9(3):193.

Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes care 2004;27(1):134-40.

Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current opinion in lipidology 2008;19(1):50-6.

Meyer JA, Spence DM. A perspective on the role of metals in diabetes: past findings and possible future directions. Metallomics 2009;1(1):32-41.

Shah SIA, Iqbal S, Sikandar MZ, Qazi, UY, Haq I. Serum Vitamin D and Cardiometabolic Markers: A Comparative Study in Adult Men Based on Body Mass Index. Int Med J Malays 2021;20(2):67-74. 10.31436/imjm.v20i2.1640.

Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians 2015;7(2):75.

Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 2010;134(2):119-29.

Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014;45(5):388-93.

Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes care 2004;27(1):59-65.

Iqbal S, Shah SIA, Sikandar MZ. Relationship between serum vitamin D and insulin resistance in normal and overweight or obese men. TPMJ 11/2019; 26(11):1810-4.

Misra A. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement. Diabetes Technol Ther 2015;17(9):667-71.

Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012;16(6):1000.

Hruby A, Meigs JB, O'donnell CJ, Jacques PF, McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes care 2014;37(2):419-27.

Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutrition reviews 2010;68(6):333-40.

Song CH, Choi WS, Oh HJ, Kim KS. Associations of serum minerals with body mass index in adult women. Eur J Clin Nutr 2007;61(5):682.

Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, Patrie JT, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes care 2005;28(5):1175-81.

Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World journal of diabetes 2015;6(10):1152.

Rodriguez-Moran MA, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes care 2003;26(4):1147-52.

Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294(1-2):1-26.

Hata A, Doi Y, Ninomiya T, Mukai N, Hirakawa Y, Hata J, et al. Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. Diabetic Medicine 2013;30(12):1487-94.



  • There are currently no refbacks.

Copyright (c) 2022. Sabiha Iqbal, Mirza Zeeshan Sikandar, Syed Imran Ali Shah, Tashfeen Ikram, Iram Imran, Shaheena Naz.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.